Enfermedad Granulomatosa Crónica

Total Page:16

File Type:pdf, Size:1020Kb

Enfermedad Granulomatosa Crónica ISSN 0186-4866 Volumen3 33 mayo-junio, 2017 EDITORIAL 299 Empatía, relación médico-paciente y medicina basada en evidencias Manuel Ramiro H, J Enrique Cruz A ARTÍCULOS ORIGINALES 303 Índice de inmunidad-inamación sistémica en sepsis Maricarmen Lagunas-Alvarado, Francisco Javier Mijangos-Huesca, José Oscar Terán-González, Mariana Guadalupe Lagunas- Alvarado, Néstor Martínez-Zavala, Isaac Reyes-Franco, Roberto Hernández-Mendiola, Wendy Josena Santillán-Fragoso, Dulce Valeria Copca-Nieto, Luis Raúl López y López, Rodolfo Ramírez-Del Pilar, Diana Saraí López-González, Sheyla Vázquez- Arteaga, Abraham Emilio Reyes-Jiménez, Dulce Leonor Alba-Rangel 310 Ecacia de la prolaxis con haloperidol vs placebo en la prevención de delirio en pacientes con alto riesgo de padecerlo hospitalizados en el servicio de Medicina Interna Diana Gabriela Ruíz-Dangú, Alejandro de Jesús Tamayo-Illescas, Germán Vargas-Ayala, Leticia Rodríguez-López, Nayeli Gabriela Jiménez-Saab 323 Efecto del uso de ultrasonido en tiempo real en la inserción del catéter venoso central Betzabe Hernández-Castañeda, Carlos Alberto Peña-Pérez 335 Diferencia sodio-cloro e índice cloro/sodio como predictores de mortalidad en choque séptico Jorge Samuel Cortés-Román, Jesús Salvador Sánchez-Díaz, Rosalba Carolina García-Méndez, Enrique Antonio Martínez- Rodríguez, Karla Gabriela Peniche-Moguel, Susana Patricia Díaz-Gutiérrez, Eusebio Pin-Gutiérrez, Gerardo Rivera Solís, Juan Marcelo Huanca-Pacaje, Edgar Castañeda-Balladares, María Verónica Calyeca-Sánchez 344 Correlación del índice plaqueta/bazo con el grado de várices esofágicas Rodolfo Ramírez-Del Pilar, Manuela del Carmen Yáñez-Montes, Kevin Giuseppe Enríquez-Peregrino, Mario Ramón García-Arias, Roberto Hernández-Mendiola, Diana Saraí López-González, Luis Raúl López-López, Wendy Josena Santillán-Fragoso, Dulce Valeria Copca-Nieto, María del Carmen Lagunas-Alvarado, Abraham Emilio Reyes-Jiménez, Dulce Leonor Alba-Rangel, José Oscar Terán-González, Luis Javier Castro-D’Franchis, Sheyla Vázquez-Arteaga ARTÍCULOS DE REVISIÓN 351 Tifus Jesús García-Acosta, César Raúl Aguilar-García, Isaac Esaú Aguilar-Arce 363 Inhibidores del cotransportador de sodio y glucosa tipo 2 (SGLT2), el riñón como objetivo en el control glucémico de la diabetes mellitus tipo 2 Marco Antonio López-Hernández 372 Tuberculosis en trasplantados renales Nasser Abdel Polanco 381 Choque séptico. Lo que sabíamos y lo que debemos saber... Brenda Gómez-Gómez, Juan Pablo Sánchez-Luna, Carlos Francisco Pérez-Beltrán, Enrique Juan Díaz-Greene, Federico L Rodríguez-Weber ARTÍCULO DE OPINIÓN 392 Los mitos alimentarios y su efecto en la salud humana Guillermo Murillo-Godínez, Lizeth Mariel Pérez-Escamilla CASOS CLÍNICOS 403 Carcinoma de células pequeñas en la unión gastroesofágica Tomás Miranda-Aquino, Silvia Esmeralda Pérez-Topete, Jorge Alberto Hernández-Portales, Alberto Casillas-Romo, Yamil López-Chuken 407 Enfermedad granulomatosa crónica Andrea Medrano-E’Vers, Alba Edna Morales-Hernández, Raúl Valencia-López, Daniel Ramón Hernández-Salcedo 415 Un caso raro de acidosis láctica persistente Edgar Dehesa-López, Daniel Antonio Hernández-Quintero, Héctor Guillermo Peña-Peredia, Rodolfo Radames Salas-Zazueta, Berenice Tamayo-García, Juan Luis Rochin-Terán 421 Granulomatosis con poliangitis, granulomatosis de Wegener Ana Gabriela León-Ortiz, John Oswaldo Guáman-Crespo, Martín de Jesús Sánchez-Zúñiga, Raúl Carrillo-Esper 427 Cardiomiopatía de takotsubo secundaria a sepsis. Una asociación poco frecuente Raúl Carrillo-Esper, Pavel Rosado-Garduño, Pedro Manuel Ramírez-Ambriz, Martín de Jesús Sánchez-Zúñiga EL RINCÓN DEL INTERNISTA 436 El monarca de las sombras Manuel Ramiro H 436 El cuerpo eléctrico Manuel Ramiro H 437 El Laberinto de los Espíritus Manuel Ramiro H REVISTA DEL COLEGIO DE MEDICINA INTERNA DE MÉXICO Indizada en: Artemisa (CENIDS) • Periódica • Directorio de Revistas Latindex • LILACS • Nivel 1. Institutos Nacionales de Salud • EBSCO www.medicinainterna.org.mx Medicina Interna de México Comité Editorial Internacional COLEGIO DE MEDICINA Jaime Merino (España) INTERNA DE MÉXICO AC Daniel Sereni (Francia) Alberto Malliani (Italia) Consejo Directivo Cristopher Davidson (Inglaterra) 2017-2018 Enrique Caballero (Estados Unidos) Estefan Lindgren (Suecia) Presidente Jan Willem Felte (Países Bajos) 3 Eduardo Meneses Sierra Moisés Aurón (EUA) Vicepresidente Marina Y. Duran Castillo (EUA) Volumen 33 Jorge Alberto Rodríguez García Primer Secretario (Secretaría General) mayo-junio, 2017 Ramón Jesús Barrera Cruz COMISIONES ESPECIALES Segundo Secretario (Actividades Científicas) Rodolfo Rincón Pedrero Comisión de Educación Médica La revista Medicina Interna de México es el órgano ofi- Tesorera César Alejandro Arce Salinas cial del Colegio de Medicina Interna de México. Revista Francisco Rafael Anaya Gómez bimestral. Editor responsable: Enrique Nieto R. Reserva Luz Gabriela Jardines De la Luz de Título de la Dirección General del Derecho de Autor Primer Vocal (Comunicación Social) (SEP) número 04-2008-011713163100-102. Certificado María Eugenia Galván Comisión de Ética Médica y Bioética de Licitud de Título número 11967 y Certificado de Segundo Vocal (Admisión y Filiales) María del Carmen Cedillo Pérez Licitud de Contenido de la Comisión Calificadora de Nikos Christo Secchi Nicolás María Antonieta Calderón Márquez Publicaciones y Revistas Ilustradas (SeGob) número Primer Secretario Suplente 8375. Autorizada por SEPOMEX como Publicación Eva María Perusquia Frías Comisión de Peritos y Servicio Social Periódica. Registro número PP09-1501. Publicación Protesorero Profesional indizada en Periódica (http://dgb.unam.mx/periodica/ html), en el Directorio de Revistas Latindex (http:// Carlos Reyes Zavala Joaquín Zúñiga Madrazo www.latindex.org), en la Base de Datos Internacional Eduardo Meneses Sierra Segundo Secretario Suplente de EBSCO (MedicLatina) y en LILACS. Rosalía García Peña Primer Vocal Suplente Comisión Editorial Publicación realizada, comercializada y distribuida por Julio César Dávila Valero Alberto Lifshitz EDICIÓN Y FARMACIA, SA de CV. Domicilio de la Segundo Vocal Suplente José Halabe Ch. publicación: Cerrada de Antonio Maceo 68, colonia Es- Javier Pedraza Chávez Ricardo Juárez Ocaña candón, 11800 Ciudad de México. Teléfono: 5678-2811. E-mail: [email protected] Editor Comisión de Honor y Justicia El contenido de los artículos firmados es responsabilidad Manuel Ramiro H. Manuel Ramiro Hernández de sus autores. Todos los derechos están reservados de Coeditores acuerdo con la Convención Latinoamericana y la Con- Asisclo de Jesús Villagómez Comisión de Relaciones Internacionales vención Internacional de Derechos de Autor. Ninguna J. Enrique Cruz Aranda Víctor Huggo Córdova Pluma parte de esta revista podrá ser reproducida por ningún Haiko Nellen Hummel medio, incluso electrónico, ni traducida a otros idiomas, Consejo Editorial sin autorización de sus editores. Impresa por Grupo Art David Kersenobich Comisión de Investigación Graph, S.A. de C.V., Av. Peñuelas 15-D, Col. San Pedrito Alberto Lifshitz G. Guadalupe Castro Martínez Peñuelas, Querétaro 76148, Qro., Tel.:(442) 220 8969. Adolfo Martínez-Palomo Alberto F Rubio Guerra La suscripción de esta revista forma parte de los ser- Guillermo J. Ruiz-Argüelles vicios que el Colegio de Medicina Interna de México Comisión de Difusión de la Medicina Interna José Sifuentes Osornio otorga a sus agremiados al corriente en el pago de sus Roberto Tapia Conyer Rodolfo de Jesús Palencia Vizcarra cuotas anuales. Olga Lidia Vera Lastra Niels Wacher R. www.medicinainterna.org.mx Medicina Interna de México Volumen 33, Núm. 3, mayo-junio, 2017 CONTENIDO CONTENTS EDITORIAL EDITORIAL 299 Empatía, relación médico-paciente y medicina 299 Empathy, physician-patient relation and evidence- basada en evidencias based medicine Manuel Ramiro H, J Enrique Cruz A Manuel Ramiro H, J Enrique Cruz A ARTÍCULOS ORIGINALES ORIGINAL ARTICLES 303 Índice de inmunidad-inflamación sistémica en sepsis 303 Systemic immune inflammatory index in sepsis Maricarmen Lagunas-Alvarado, Francisco Javier Maricarmen Lagunas-Alvarado, Francisco Javier Mijangos-Huesca, José Oscar Terán-González, Mijangos-Huesca, José Oscar Terán-González, Mari- Mariana Guadalupe Lagunas-Alvarado, Néstor ana Guadalupe Lagunas-Alvarado, Néstor Martínez- Martínez-Zavala, Isaac Reyes-Franco, Roberto Zavala, Isaac Reyes-Franco, Roberto Hernández- Hernández-Mendiola, Wendy Josefina Santillán- Mendiola, Wendy Josefina Santillán-Fragoso, Dulce Fragoso, Dulce Valeria Copca-Nieto, Luis Raúl López Valeria Copca-Nieto, Luis Raúl López y López, y López, Rodolfo Ramírez-Del Pilar, Diana Saraí Rodolfo Ramírez-Del Pilar, Diana Saraí López- López-González, Sheyla Vázquez-Arteaga, Abraham González, Sheyla Vázquez-Arteaga, Abraham Emilio Emilio Reyes-Jiménez, Dulce Leonor Alba-Rangel Reyes-Jiménez, Dulce Leonor Alba-Rangel 310 Eficacia de la profilaxis con haloperidol vs placebo 310 Efficacy of prophylaxis with haloperidol vs placebo en la prevención de delirio en pacientes con alto in the prevention of delirium in patients with risk riesgo de padecerlo hospitalizados en el servicio de of suffering it hospitalized in an Internal Medicine Medicina Interna service Diana Gabriela Ruíz-Dangú, Alejandro de Jesús Diana Gabriela Ruíz-Dangú, Alejandro de Jesús Tamayo-Illescas, Germán Vargas-Ayala, Leticia Tamayo-Illescas, Germán Vargas-Ayala, Leticia Rodríguez-López, Nayeli Gabriela Jiménez-Saab Rodríguez-López, Nayeli Gabriela Jiménez-Saab 323 Efecto del uso de ultrasonido en tiempo real en la 323 Effect of
Recommended publications
  • Pathology and Classification of SCLC
    cancers Review Pathology and Classification of SCLC Maria Gabriela Raso * , Neus Bota-Rabassedas and Ignacio I. Wistuba * Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; [email protected] * Correspondence: [email protected] (M.G.R.); [email protected] (I.I.W.); Tel.: +1-713-834-6026 (M.G.R.); +1-713-563-9184 (I.I.W.) Simple Summary: Small cell lung carcinoma (SCLC), is a high-grade neuroendocrine carcinoma defined by its aggressiveness, poor differentiation, and somber prognosis. This review highlights cur- rent pathological concepts including classification, immunohistochemistry features, and differential diagnosis. Additionally, we summarize the current knowledge of the immune tumor microenvi- ronment, tumor heterogeneity, and genetic variations of SCLC. Recent comprehensive genomic research has improved our understanding of the diverse biological processes that occur in this tumor type, suggesting that a new era of molecular-driven treatment decisions is finally foreseeable for SCLC patients. Abstract: Lung cancer is consistently the leading cause of cancer-related death worldwide, and it ranks as the second most frequent type of new cancer cases diagnosed in the United States, both in males and females. One subtype of lung cancer, small cell lung carcinoma (SCLC), is an aggressive, poorly differentiated, and high-grade neuroendocrine carcinoma that accounts for 13% of all lung carcinomas. SCLC is the most frequent neuroendocrine lung tumor, and it is commonly presented as an advanced stage disease in heavy smokers. Due to its clinical presentation, it is typically diagnosed in small biopsies or cytology specimens, with routine immunostaining only. However, Citation: Raso, M.G.; immunohistochemistry markers are extremely valuable in demonstrating neuroendocrine features of Bota-Rabassedas, N.; Wistuba, I.I.
    [Show full text]
  • Leishmania Infection and Neuroinflammation
    Journal of Neuroimmunology 289 (2015) 21–29 Contents lists available at ScienceDirect Journal of Neuroimmunology journal homepage: www.elsevier.com/locate/jneuroim Leishmania infection and neuroinflammation: Specific chemokine profile and absence of parasites in the brain of naturally-infected dogs Guilherme D. Melo a,1, José Eduardo S. Silva a,FernandaG.Granoa,MilenaS.Souzab,GiseleF.Machadoa,⁎ a Faculdade de Medicina Veterinária, UNESP – Univ Estadual Paulista, Laboratório de Patologia Aplicada (LApap), Araçatuba, São Paulo, Brazil b Faculdade de Medicina Veterinária, UNESP – Univ Estadual Paulista, Araçatuba, São Paulo, Brazil article info abstract Article history: Visceral leishmaniasis is a chronic disease caused by Leishmania infantum. We aimed to detect the parasite in the Received 24 June 2015 brain of fifteen naturally-infected dogs using in situ hybridization and immunohistochemistry, and the gene ex- Received in revised form 28 August 2015 pression of selected chemokines by RT-qPCR. We detected no parasite in the brain, but perivascular deposition of Accepted 8 October 2015 parasite DNA and IgG in the choroid plexus. We noticed up-regulation of CCL-3, CCL-4 and CCL-5, coherent with T lymphocyte accumulation, stating the brain as a pro-inflammatory environment. Indeed, not necessarily the par- Keywords: fl Chemokine CCL3 asite itself, but rather its DNA seems to act as a trigger to promote brain in ammation during visceral Chemokine CCL4 leishmaniasis. Chemokine CCL5 © 2015 Elsevier B.V. All rights reserved. Central nervous system Tlymphocytes Visceral leishmaniasis 1. Introduction Specifically in the brain, the parasite is not often detected (Márquez et al., 2013; Viñuelas et al., 2001), however, inflammatory lesions even Visceral leishmaniasis (VL) is a chronic disease caused by parasitic in the absence of the parasite are commonly observed, predominantly protozoans from the Leishmania donovani complex, namely L.
    [Show full text]
  • Primary Neuroendocrine Small Cell Carcinoma in Larynx
    Romanian Journal of Rhinology, Vol. 7, No. 27, July - September 2017 DOI: 10.1515/rjr-2017-0021 CASE REPORT Primary neuroendocrine small cell carcinoma in larynx: case report and literature review Anca Evsei1,2 , Cristina Iosif2, Simona Enache2,3, Claudiu Manea1,4, Codrut Sarafoleanu1,4 1CESITO Center, “Sfanta Maria” Clinical Hospital, Bucharest, Romania 2Department of Pathology, “Sfanta Maria” Clinical Hospital, Bucharest, Romania 3“Victor Babes” National Institute of Research – Development in the Pathology Domain and Biomedical Sciences, Bucharest, Romania 4ENT&HNS Department, “Sfanta Maria” Clinical Hospital, Bucharest, Romania ABSTRACT BACKGROUND. Neuroendocrine tumors of the larynx represent a rare group of neoplasms characterized by pathological and biological heterogeneity. The histological and immunohistochemical diagnosis is the most important step in the appropri- ate management of these tumors and the prognosis varies according to histological types. Conventional anatomical and func- tional imaging can be complementary for diagnosis, staging and monitoring of treatment response. MATERIAL AND METHODS. Here we report on a case of a laryngeal neuroendocrine small cell carcinoma occurring in a 67-year-old man who was referred to our clinic for clinical reevaluation, diagnosis and treatment. The clinical presentation, the histopathological and immunohistochemical examination and management of this kind of tumor are highlighted. CONCLUSION. Small cell neuroendocrine carcinomas are very aggressive neoplasms. Patients could benefit from surgery, but radiotherapy and chemotherapy remain the treatment of choice. Very low incidence of neuroendocrine tumors in the larynx and specifically very poor prognosis of neuroendocrine small cell carcinoma encouraged an extensive literature review. KEYWORDS: small cell carcinoma, laryngeal, neuroendocrine, prognosis. INTRODUCTION group of neoplasms, which share specific pathological and immunohistochemical features, with prognosis Neuroendocrine neoplasms of the larynx are a het- dependent on the tumor type.
    [Show full text]
  • Neuroendocrine Neoplasms Natasha Rekhtman, MD, Phd*
    24 Neuroendocrine Neoplasms Natasha Rekhtman, MD, PhD* General Definitions The subject of neuroendocrine neoplasms, starting with the definition of what neuroendocrine means, is thoroughly confusing to the beginner. This chapter reviews the basic concepts and definitions pertaining to this subject. Let us start with a definition of neuroendocrine. As the term implies, there are two components: “neuro” and “endocrine.” The “endocrine” quality refers to the secretory nature of neuroendocrine cells: they produce and secrete peptides and amines. The “neuro” quality refers to their ultrastruc- tural similarity to neurons: neuroendocrine cells store their secretory products in granules (i.e., dense-core granules), which bear resemblance to synaptic vesicles. Neuroendocrine cells are dif- ferent from neurons structurally (no processes) and by the fact that the secretory mode is paracrine rather than synaptic. Also note that not all that secretes is neuroendocrine: for example, thyroid and adrenal cortex are not neuroendocrine because their cells do not possess neurosecretory granules (they are simply endocrine). Thus, at the most basic level, neuroendocrine cells are defined as the presence of neurosecretory granules in nonneurons. Tumors derived from these cells have a char- acteristic “neuroendocrine morphology” and share expression of “neuroendocrine markers.” Neuroendocrine Markers In the past, neurosecretory granules were identified by electron microscopy and special stains. Currently these methods have been completely supplanted by immunohistochemical markers. These are called neuroendocrine markers and they include synaptophysin (SYN), chromogranin (CHR), neural-specific enolase (NSE), and CD56 (SYN and CHR specifically recognize dense-core granules). Note that these markers also recognize true neurons and neu- roblastic cells (primitive neurons).
    [Show full text]
  • Kikuchi-Fujimoto Disease Preceded by Lupus Erythematosus Panniculitis: Do These Findings Together Herald the Onset of Systemic Lupus Erythematosus?
    Volume 26 Number 8| Aug 2020| Dermatology Online Journal || Case Report 26(8):6 Kikuchi-Fujimoto disease preceded by lupus erythematosus panniculitis: do these findings together herald the onset of systemic lupus erythematosus? Anh Khoa Pham1, Stephanie A Castillo2, Dorothea T Barton1,2, William FC Rigby2,3, Marshall A Guill III1,2, Roberta Lucas1,2, Robert E LeBlanc2,4 Affiliations: 1Department of Dermatology, Dartmouth-Hitchcock Medical Center, New Hampshire, USA, 2Geisel School of Medicine at Dartmouth College, New Hampshire, USA, 3Section of Rheumatology, Department of Medicine, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, USA, 4Department of Pathology and Laboratory Medicine, Dartmouth-Hitchcock Medical Center, New Hampshire, USA Corresponding Author: Robert E LeBlanc, MD, Department of Pathology and Laboratory Medicine, Dartmouth-Hitchcock Medical Center, and Geisel School of Medicine, One Medical Center Drive, Lebanon, NH 03756, Email: [email protected] Introduction Abstract Kikuchi-Fujimoto Disease (KFD), also known as Kikuchi-Fujimoto disease (KFD), also known as histiocytic necrotizing lymphadenitis, is a rare histiocytic necrotizing lymphadenitis, is a rare disorder that must be distinguished from systemic disorder that must be distinguished from systemic lupus erythematosus (SLE). It is characterized by lupus erythematosus (SLE). Although a minority of painful cervical lymphadenopathy, leukopenia, and patients with KFD develop SLE, most patients have a systemic symptoms including fever and malaise self-limited disease. Importantly, KFD can have skin [1,2]. The etiology of KFD is unknown, but infectious manifestations resembling cutaneous lupus. and autoimmune etiologies have been postulated Therefore, the diagnosis of SLE should be predicated [2]. A correlation between KFD and SLE is well- on a complete rheumatologic workup and not on the documented, with reports of SLE diagnoses constellation of skin disease and lymphadenitis.
    [Show full text]
  • Tumores Neuroendocrinos Del Tracto Urinario
    Tumores Neuroendocrinos del Tracto Urinario Antonio López-Beltrán Córdoba Introduction • Three basic types of neuroendocrine (NE) tumours with diverse clinicopathological features and outcome are identified in the urinary system and male genital organs: • Carcinoid tumour (typical and atypical) • Small cell carcinoma (SCC) • Large cell NE carcinoma (LCNEC), • Morphologically, histochemically, immunohistochemically and ultrastructurally similar to its counterpart in other organs, such as lung or gastrointestinal tract. • Metastases can be detected at the initial evaluation, although they have been reported up to several years after removal (carcinoid), emphasizing the need for a long-term follow-up. • Although the occurrence is rare, SCC and LCNEC are highly aggressive. Introduction • Neuroendocrine (NE) tumours represent a heterogeneous group of neoplasms originating from NE cells. • Such cells are either present in endocrine organs or dispersed through the body, and produce neurotransmitters, neuromodulators or neuropeptide hormones. • The NE cells are defined immunohistochemically by the presence in the cytoplasm of markers, such as chromogranin A and neurone- specific enolase (NSE) • Show dense-core granules at the ultrastructural level. • The classification of the NE tumours largely depends upon the anatomical site and organ of origin. In the lung NE tumours include four groups of neoplasms with diverse prognosis – Typical and atypical carcinoid, large-cell NE carcinoma (LCNEC) and small cell carcinoma (SCC). Introduction • Potential origins of the NE neoplasms of the urinary system and male genital organs are: • (i) Derivation from NE cells of the diffuse NE system, e.g. those identified in the normal urothelial tract and prostate and which might increase in number in reactive or metaplastic settings • (ii) Derivation from a multipotent stem cell, a concept crucial to understanding the nature of NE tumours arising in conjunction with epithelial or germ cell malignancies, which might express markers of both components.
    [Show full text]
  • A Rare Clinical Entity of Cervical Lymphadenopathy with Review of Literature 1Sudhir M Naik, 2BL Yatish Kumar, 3S Ravishankara, 4T Shashikumar, 5R Navya, 6P Sathya
    AIJOC Kikuchi’s Disease: A Rare Clinical Entity of Cervical Lymphadenopathy10.5005/jp-journals-10003-1241 with Review of Literature ORIGINAL ARTICLE Kikuchi’s Disease: A Rare Clinical Entity of Cervical Lymphadenopathy with Review of Literature 1Sudhir M Naik, 2BL Yatish Kumar, 3S Ravishankara, 4T Shashikumar, 5R Navya, 6P Sathya ABSTRACT uncommon, idiopathic, generally self-limited cause of 1,2 Background and objectives: Kikuchi disease is an uncom- lymphadenitis. The disease runs a self-limiting course mon, idiopathic, generally self-limited cause of lymphadenitis. usually resolving in 6 to 8 months of occurrence, with The disease runs a self-limiting course usually resolving in the usual clinical manifestations being cervical lymph- 6 to 8 months of occurrence, with the usual clinical manifesta- adenopathy, with or without systemic manifestations.3-6 tions being cervical lymphadenopathy, with or without systemic Earlier, the disease was misdiagnosed as lymphoma or manifestations. systemic lupus erythematosus (SLE) with minimal recur- Materials and methods: A retrospective study was done rences and complications.1-6 in three cases of Kikuchi disease reported over 2 years. All three females had cervical lymphadenopathy not responding to empirical treatment. All had excision of the lymph nodes MATERIALS AND METHODS with immunohistochemistry, which suggested the necrotizing We report three cases of this disease reported in our lymphadenopathy. Other similar diagnoses, like systemic lupus department over the past 5 years. All the three were erythematosus, non-Hodgkin’s lymphoma, Kawasaki, tubercu- lous, metastatic lymphadenopathy, were excluded. females around the 5th to 6th decade (mean age—51 years). They presented with cervical lymphadenopathy not sub- Conclusion: The rare possibility of cervical lymphadenopathy sided by two courses of antibiotics and anti-inflammatory being Kikuchi’s disease should be thought if empirical therapy fails.
    [Show full text]
  • Pathogenesis, Diagnosis, and Management of Kikuchi–Fujimoto Disease Darcie Deaver, Phd, Pedro Horna, MD, Hernani Cualing, MD, and Lubomir Sokol, MD, Phd
    Kikuchi–Fujimoto disease is a rare lymphohistiocytic disorder that affects young women of Asian descent more frequently than persons of other ethnic groups. Net-Wing Beetle. Photograph courtesy of Sherri Damlo. www.damloedits.com. Pathogenesis, Diagnosis, and Management of Kikuchi–Fujimoto Disease Darcie Deaver, PhD, Pedro Horna, MD, Hernani Cualing, MD, and Lubomir Sokol, MD, PhD Background: Kikuchi–Fujimoto disease (KFD) is a rare lymphohistiocytic disorder with an unknown etiopathogenesis. This disease is misdiagnosed as malignant lymphoma in up to one-third of cases and is as- sociated with the development of systemic lupus erythematosus (SLE). Methods: The medical literature between the years 1972 and 2014 was searched for KFD, and the data were collected and analyzed regarding the epidemiology, clinical presentations, diagnosis, management, and suggested diagnostic and treatment algorithms. Results: Although KFD has been reported in other ethnic groups and geographical areas, it is more frequently diagnosed in young women of Asian descent. Patients with the disease typically present with rapidly evolving tender cervical lymphadenopathy, night sweats, fevers, and headache. Diagnosis is based on histopathological examination. Excisional lymph node biopsy is essential for a correct diagnosis. Apoptotic coagulation necrosis with karyorrhectic debris and the proliferation of histiocytes, plasmacytoid dendritic cells, and CD8+ T cells in the absence of neutrophils are characteristic cytomorphology features. Interface dermatitis at the onset of KFD may be a marker for the subsequent evolution of SLE. The natural course of the disease is typically benign. Short courses of steroids, nonsteroidal anti-inflammatory drugs, or hydroxychloroquine can be administered to patients with more severe symptoms. Conclusions: Although KFD was described more than 40 years ago, the etiology of this disease remains un- solved.
    [Show full text]
  • A Case of Brucellosis Associated with Histiocytic Necrotizing Lymphadenitis: a Diagnostic Pitfall
    J Interdiscipl Histopathol 2013; 1(5): 274-279 ISSN: 2146-8362 Case Report A Case of Brucellosis Associated With Histiocytic Necrotizing Lymphadenitis: A Diagnostic Pitfall Nicole Dalton Wheeler1, Marian Rollins-Raval2,3, Steven H. Swerdlow3, Swati Modi4, Kimberly Liang4, Robyn T. Domsic4, and Kathleen R. Sheridan1 1Department of Infectious Diseases, University of Pittsburgh Medical Center, Pittsburgh, PA 15213, USA 2Department of Pathology and Laboratory Medicine, University of North Carolina, Chapel Hill, NC 27599-7525, USA 3Division of Hematopathology, Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, PA 15213, USA 4Division of Rheumatology and Clinical Immunology, University of Pittsburgh Medical Center, Pittsburgh, PA 15261, USA Received: June 26, 2013 Abstract Accepted: July 22, 2013 Human cases of brucellosis are rare in the United States and difficult to diagnose. We report a case of a young female who underwent a diagnostic investigation of Published Online: July 24, 2013 fever of unknown origin, which included a lymph node biopsy. The biopsy was DOI: 10.5455/jihp.20130722113848 consistent with Kikuchi’s Disease, or histiocytic necrotizing lymphadenitis, an entity where the major differential diagnosis is systemic lupus erythematosus. Corresponding Authors: Interestingly, serologic studies supported the diagnosis of brucellosis. Brucellosis Nicole Dalton Wheeler, MD has rarely been associated with histiocytic necrotizing lymphadenitis. This Kathleen Sheridan, MD association has never been reported in the United States, thus suggesting that Department of Infectious Diseases, University of Pittsburgh Medical Center, brucellosis should be considered in the differential for histiocytic necrotizing 3601 Fifth Avenue, 3rd floor Falk Medical lymphadenitis, along with lupus-like autoimmune disease. As the prognosis and Building, Suite 3A, Pittsburgh, PA 15213, treatment of histiocytic necrotizing lymphadenitis, brucellosis, and systemic lupus USA erythematosus are distinct, it is important to differentiate these entities.
    [Show full text]
  • A Useful Marker in Differentiating Pulmonary Small Cell Carcinoma from Merkel Cell Carcinoma
    Modern Pathology (2008) 21, 1357–1362 & 2008 USCAP, Inc All rights reserved 0893-3952/08 $30.00 www.modernpathology.org MASH1: a useful marker in differentiating pulmonary small cell carcinoma from Merkel cell carcinoma Jonathan Ralston, Luis Chiriboga and Daisuke Nonaka Department of Pathology, New York University School of Medicine, New York, NY, USA Merkel cell carcinoma is the cutaneous counterpart of small cell carcinoma, and the most important differential diagnosis is cutaneous metastasis of small cell carcinoma of the lung. There have been a handful of studies reporting on the utility of a variety of immunohistochemical markers that distinguish between the two entities. Achaete-scute complex-like 1 (MASH1, ASCL1) is important in the development of the brain and the diffuse neuroendocrine system including pulmonary neuroendocrine cells. A recent study, using a cDNA array, identified Mash1 as one of the best classifier genes to differentiate pulmonary small cell carcinoma from Merkel cell carcinoma. We immunohistochemically applied this finding to the diagnostic setting. A total of 30 cases of Merkel cell carcinoma and 59 cases of small cell carcinoma of the lung were immunostained with anti-MASH1 and TTF-1 antibodies. Of 59 small cell carcinomas, 49 (83%) expressed MASH1 in nuclear staining whereas out of 59 small cell carcinomas, 43 (73%) expressed TTF-1 in nuclear staining. MASH1 was completely negative in all 30 Merkel cell carcinomas whereas TTF-1 expression was seen in 1 of the 30 Merkel cell carcinomas (3%). MASH1 is a useful adjunct marker for differentiating small cell carcinoma of the lung from Merkel cell carcinoma.
    [Show full text]
  • 2011 Board Review Course
    2011 Board Review Course 48th Annual Meeting October 20-23, 2011 Sheraton Seattle Seattle, Washington 2011 Board Review The American Society of Dermatopathology Faculty: Thomas N. Helm, MD, Course Director State University of New York at Buffalo Alina Bridges, DO Mayo Clinic, Rochester Klaus J. Busam, MD Memorial Sloan-Kettering Cancer Center Loren E. Clarke, MD Penn State Milton S. Hershey Medical Center/College of Medicine Tammie C. Ferringer, MD Geisinger Medical Center Darius R. Mehregan, MD Pinkus Dermatopathology Lab PC Diya F. Mutasim, MD University of Cincinnati Rajiv M. Patel, MD University of Michigan Margot S. Peters, MD Mayo Clinic, Rochester Garron Solomon, MD CBLPath, Inc. COURSE OBJECTIVES Upon completion of this course, participants should be able to: Identify board examination requirements. Utilize new technology to assist with various diagnoses and treatment methods. Structure and Function of the Skin Alina Bridges, DO Mayo Clinic, Rochester Structure and Function of the Epidermis Alina G. Bridges, D.O. Assistant Professor, Department of Dermatopathology, Division of Dermatopathology and Cutaneous Immunopathology, Mayo Clinic, Rochester, MN I. Functions A. Protection B. Sensory reception C. Thermal regulation D. Nutrient (Vitamin D) metabolism E. Immunologic surveillance 1.Keratinocytes produce interleukins, colony stimulating factors, tumor necrosis factors, transforming growth factors and growth F. Repair II. Epidermis A. Derived from ectoderm B. Keratinizing stratified squamous epithelium from which arise cutaneous appendages (sebaceous glands, nails and apocrine and eccrine sweat glands) 1. Rete 2. Dermal papillae C. Comprises the following layers a) Stratum germinativum (Basal cell layer) b) Stratum spinosum (Spinous Cell layer) c) Stratum granulosum (Granular layer) d) Stratum corneum (Horny cell layer) e) Stratum lucidum present in areas where the stratum corneum is thickest, such as the palms and soles.
    [Show full text]
  • Clinical Review Neuroendocrine Neoplasms of the Larynx: an Overview
    CLINICAL REVIEW David W. Eisele, MD, Section Editor NEUROENDOCRINE NEOPLASMS OF THE LARYNX: AN OVERVIEW Alfio Ferlito, MD, DLO, DPath, FRCS, FRCSEd, FRCSGlasg, FRCSI, FHKCORL, FDSRCS, FRCPath, FASCP, IFCAP,1 Carl E. Silver, MD,2 Carol R. Bradford, MD,3 Alessandra Rinaldo, MD, FRCSI1 1 Department of Surgical Sciences, ENT Clinic, University of Udine, Udine, Italy. E-mail: [email protected] 2 Departments of Surgery and Otolaryngology–Head and Neck Surgery, Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, New York 3 Department of Otolaryngology–Head and Neck Surgery, University of Michigan, Ann Arbor, Michigan Accepted 24 March 2009 Published online 17 June 2009 in Wiley InterScience (www.interscience.wiley.com). DOI: 10.1002/hed.21162 proven to be of a little benefit. Paragangliomas are treated by Abstract: Neuroendocrine neoplasms of the larynx are local excision or partial laryngectomy. rare but are the most common nonsquamous tumors of this It is difficult to determine the valid survival statistics for typical organ. In the past, there has been considerable confusion carcinoids because of their rarity and confusion in the literature about the nature and classification of these neoplasms, but the with their atypical counterparts. They have a greater tendency to current consensus is that there are 4 different types of laryn- metastasize, and thus a worse prognosis than was previously geal neuroendocrine tumors composed of paraganglioma, typi- believed. Atypical carcinoid tumors have a 5-year survival rate of cal carcinoid, atypical carcinoid tumor, and small cell approximately 50%, which decreases with time. The prognosis of neuroendocrine carcinoma. Carcinoids and small cell neuroen- small cell neuroendocrine carcinoma of the larynx is dismal, with 5- docrine carcinomas are epithelial neoplasms, whereas para- year survival rates of 5%.
    [Show full text]